1 / 24

CLINICAL ASPECTS OF BIOCHEMISTRY NEURODEGENERATIVE DISEASES Prion diseases Alzheimer's disease

CLINICAL ASPECTS OF BIOCHEMISTRY NEURODEGENERATIVE DISEASES Prion diseases Alzheimer's disease. SOME PRION DISEASES TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES. SPONGIFORM BRAIN TISSUE. From Prusiner (1998). HOW CAN PROTEINACEOUS PARTICLE BE INFECTIOUS?.

donat
Télécharger la présentation

CLINICAL ASPECTS OF BIOCHEMISTRY NEURODEGENERATIVE DISEASES Prion diseases Alzheimer's disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CLINICAL ASPECTS OF BIOCHEMISTRY NEURODEGENERATIVE DISEASES Prion diseases Alzheimer's disease

  2. SOME PRION DISEASES TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES

  3. SPONGIFORM BRAIN TISSUE From Prusiner (1998)

  4. HOW CAN PROTEINACEOUS PARTICLE BE INFECTIOUS? May contain "shielded" nucleic acid? Proteins specify own aa sequence? Normal cells carry a gene that encodes PrP, and the product is changed to a different conformation by the infectious particle?

  5. THE PRION HYPOTHESIS TSEs occur when the normal ‘cellular’ form of the prion protein (PrPc) is converted to the abnormal form (PrPsc). PrPc and PrPsc differ in conformation. The conversion is ‘autocatalytic’ - PrPsc facilitates the conversion of more PrPc to PrPsc.

  6. TSEs - MAIN TOPICS 1. The nature of PrPc and PrPsc Conversion of PrPc toPrPsc Inherited TSEs Species specificity and species barriers Strains Normal function; role in disease Doppel BSE and nvCJD Therapies?

  7. Normal (PrPc) and abnormal (PrPs) forms of prion protein • PrPc • Precursor ~ 250 amino acids. MaturePrPc ~ 210 aas • Hydrophobic glycoprotein • GPI anchor (glucosyl phosphatidyl inositol) • NMR structure - C-terminal end a-helical, N-terminal end unordered • PrPsc • Same sequence and postranslational modifications as PrPc • Different conformation - more b-sheet • Tends to form insoluble aggregates • More resistant to proteolysis than PrPc • Insoluble PrPsc (in amyloid plaques) not infectious?

  8. PrPSc IS RESISTANT TO PROTEOLYSIS -PK +PK PrPSc PrPC PrPSc PrPC Based on Priola (2001)

  9. STRUCTURE OF THE HUMAN PRION PROTEIN Globular domain Based on Rivera-Milla et al (2003)

  10. HYPOTHETICAL MODELS FOR PrPc AND PrPsc Based on Prusiner (1998)

  11. alpha helix beta sheet

  12. PrPSc CAN CONVERT PrPC TO PrPScIN VITRO Based on Priola (2001)

  13. PrPSc PrPC (a) (b) EtcEtc ~6 Very slow fast fast fast TWO MODELS FOR CONVERSION OF PrPC TO PrPSc

  14. INHERITED FORMS OF CJD, GSS, FFI etc Mutations may stabilise PrPsc conformation e.g. P102L in GSS [when this was engineered into mice they developed 'scrapie') Met/Val129polymorphism in man - Val homozygotes more susceptible to CJD? Met homozygotes more susceptible to nvCJD?

  15. SOME POINT MUTATIONS IN THE PrP GENE THAT CAUSE HUMAN PRION DISEASE Based on Priola (2001)

  16. SPECIES BARRIERS TO TRANSFER OF PrPSc Sequence differences between PrP from different species may provide (and explain?) some barrier to infection - but incomplete. E.g. Mouse  mouse transfer gives more rapid infection than mouse  hamster etc. But, mouse  hamster hamster gives faster infection, Homologous PrPSc is better at converting PrPC than heterologous

  17. STRAINS OF PRION DISEASES Scrapie occurs as about 20 different strains (differentiated by time taken to infect mice and different behavioural effects). CJD occurs as 2-4 different strains. BSE only one. May be explicable in terms of different conformations, but the more strains the more far-fetched this explanation. The biggest problem with the Prusiner model? For 2 CJD strains - evidence for different conformations (pattern of proteolysis)

  18. -PK +PK DIFFERENT PrPSc STRAINS - DIFFERENT CONFORMATIONS Based on Priola (2001)

  19. NORMAL FUNCTION OF PRPC Not clear; knockout mice lacking PrP are not seriously abnormal Possible roles in cell signalling and in processing copper ions have been suggested WHY DOES PrPSc CAUSE DISEASE? • Possible explanations include: • Neurotoxic • Deposits disrupt cells • Deposits disrupt intercellular contacts (synapses etc) • Loss of PrPC

  20. DOPPEL (Dpl) A PrP-like protein (~25% sequence identity but shorter). Gene close to PrP gene - could explain variable effect of PrP knockouts Involvement in prion diseases? Based on Behrens & Aguzzi (2002)

  21. 40,000 30,000 Number of BSE cases 20,000 10,000 16 83 663 85 86 87 88 89 90 91 92 93 94 95 96 Year of epidemic ANNUAL INCIDENCE OF BSE IN THE UK

  22. nvCJD incidence 30 25 20 15 10 5 0 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004

  23. nvCJD incidence 30 40,000 25 30,000 20 Number of BSE cases 20,000 15 10 10,000 5 85 86 87 88 89 90 91 92 93 94 95 96 0 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 Year of epidemic

  24. CJD - POSSIBLE THERAPIES • Drugs that stabilise PrPC (stabilise helical conformation) • Drugs that inhibit aggregation & amyloid (b sheet) formation • Immunization against PrPC or PrPSc

More Related